We demonstrate that the Sox9 regulation of β‐catenin, CCL2, and GDNF constitutes a pivotal mechanism in pain signaling, suggesting that modulation of this pathway may represent a promising therapeutic strategy for intervertebral disc degeneration and its concomitant pain. This evidence concerns the gene SOX9 and Intervertebral disk degeneration.